Safety Centre

Lumps, Granulomas and Vascular Occlusion after Collagen Fillers

After collagen-stimulating fillers (commonly called 'collagen injections'), the most frequently reported problem is a lump that can be felt under the skin. Most small lumps that appear within weeks, do not hurt and cannot be seen from the outside are caused by the product collecting in one spot and often decrease on their own. Lumps that appear months later and become red, grow or hurt, however, may be an inflammatory reaction (granuloma) and need an examination. Because these products cannot be dissolved with the enzyme hyaluronidase, the treatment options both for lumps and for the rare event of vascular occlusion are different from, and more limited than, those for hyaluronic acid fillers.

What kinds of problems occur after collagen-stimulating filler?

The products commonly called 'collagen injections' or 'collagen filler' are, in medical terms, collagen-stimulating (biostimulator) fillers. This article covers three active substances: poly-L-lactic acid, calcium hydroxylapatite and polycaprolactone. How these products work, who they are suitable for, the debate about massage and aftercare are explained in our article “Collagen-Stimulating Fillers”; here we focus only on the problems that can arise after the treatment.

Swelling, redness, tenderness and bruising at the needle points in the first days can occur with any injection and usually pass on their own. The most common problem specific to this group of products, however, is a lump (nodule: a firm bump that can be felt under the skin). In a review bringing together 21 studies on calcium hydroxylapatite, adverse events were reported in about 3 per cent of 5,081 treatments; the great majority of these were lumps, and most lumps could not be seen from the outside and passed on their own. The U.S. Food and Drug Administration (FDA) states that side effects such as lumps and granulomas can appear weeks, months or even years after fillers. The most serious but rare problem is the product blocking a blood vessel.

Tool for this articleIs this normal? A 30-second check

Tick what you have noticed since your treatment. This check is built from the table in this article; it does not diagnose and does not replace an examination by a physician.

Do you have any of these?
Do you have any of these?

May be considered normal (keep an eye on it)

You have not ticked any of the signs listed. The article lists these as expected:

  • Swelling and tenderness that increase in the first days and then decrease
  • Well-defined bruises at the needle points that turn yellow and fade over time
  • A small, unchanging firm spot in the first weeks that does not hurt and can only be felt when touched
  • A mild feeling of tightness or fullness when touched
  • The fullness of the first day decreasing as the carrier fluid is absorbed

If your symptoms get worse or something new appears, consult your physician.

This check is based only on the table in this article and does not cover every possibility. If you feel unwell, see a physician without waiting for the result.

May be considered normal (keep an eye on it)Consult your physicianEmergency (112)
Swelling and tenderness that increase in the first days and then decreaseSwelling that does not decrease or increases again as the days passBlurred vision, loss of vision, double vision or severe pain in the eye
Well-defined bruises at the needle points that turn yellow and fade over timeWhitening, a purplish colour spreading like a net or increasing pain in the treated area (the same day; if you cannot reach your physician, the emergency department)Slurred speech, facial drooping, weakness or numbness in an arm or leg
A small, unchanging firm spot in the first weeks that does not hurt and can only be felt when touchedA lump that becomes visible, grows or increases in numberShortness of breath; rapidly increasing swelling of the lips, tongue or throat
A mild feeling of tightness or fullness when touchedA lump that appears weeks or months later and turns red, feels warm or hurts—
The fullness of the first day decreasing as the carrier fluid is absorbedFever, discharge, rapidly spreading redness (may be an infection; the same day)—

If you have one of the symptoms in the last column of the table, call 112 (or your local emergency number). What to do in the case of a sudden colour change and pain is explained step by step in our article “After Fillers: When Is It an Emergency? Vascular Occlusion and Other Warning Signs”.

An early lump or an inflammatory lump (granuloma)?

Scientific sources divide the lumps that appear after these products into two main groups. The first is non-inflammatory lumps: they are mostly noticed a few weeks after the treatment, can be felt when touched, do not hurt and usually cannot be seen from the outside. A review on poly-L-lactic acid states that these lumps are largely due to the product being prepared or placed in an unsuitable way and that most of them pass on their own.

The second group is inflammatory lumps and granulomas. A granuloma is an excessive inflammatory response of the body to filler particles (a foreign body reaction). The same review reports that true granulomas due to poly-L-lactic acid are very rare, can appear months or years later and can grow over time. An international expert consensus published in 2026 also recommends classifying poly-L-lactic acid lumps as non-inflammatory and inflammatory, and emphasises that the inconsistent use of terms in this field leads to uncertainty in treatment.

FeatureNon-inflammatory (early) lumpInflammatory lump and granuloma
When does it appear?Mostly in the first weeksMostly months, sometimes years later
How does it feel?Firm, small, does not hurt; usually felt only when touchedFirm; may be tender or painful, may grow
What does it look like?Often not visible from the outside; normal skin colourMay be accompanied by redness or a purplish colour and swelling
How common is it?The most frequently reported problem with these productsRare
Possible causeThe product collecting in one spot, being injected too close to the surface, unsuitable preparationAn excessive inflammatory response of the body to the particles
General courseOften decreases over time; sometimes an intervention is neededMay not pass on its own; more difficult to treat

This table is a general framework; not every lump fits neatly into one of these two groups. Infection can also cause lumps and swelling; fever, warmth and discharge point in that direction. Only the physician who examines you can decide which type it is; if necessary, imaging methods such as ultrasound, and sometimes a tissue sample (biopsy), are used.

Not every firm spot you can feel after collagen-stimulating filler means there is a problem; most small lumps that appear in the first weeks and do not hurt decrease over time. What matters most to me is that you bring a lump that appears months later, turns red or grows to an examination rather than trying to massage it away. Because these products cannot be dissolved, keeping the product name and the date of the treatment makes our work much easier if a problem arises.

Dr. Hamza GemiciDr. Hamza Gemici
Medical Director, Doktorclub · Aesthetic Medicine Physician

What has been reported with which substance?

  • Poly-L-lactic acid: non-inflammatory lumps are the most widely known problem with this product. Granulomas have been reported very rarely; one review gives a frequency of roughly between one in ten thousand and one in a thousand.
  • Calcium hydroxylapatite: the great majority of reported adverse events are lumps. The review states that about half of these lumps were seen in 'mobile' areas such as the lips. Granulomas have been reported at the level of individual cases.
  • Polycaprolactone: there are fewer published data. Cases of granuloma have been reported; in a series of four cases, these appeared as firm lumps under the skin that did not hurt and were assessed with ultrasound.

In a systematic review examining granulomas related to collagen-stimulating fillers (40 studies, 117 patients), a substantial proportion of cases were associated with poly-L-lactic acid and calcium hydroxylapatite; the time until the first symptom ranged from one week to 15 years. Because this review also included a product that does not dissolve in the body, the long time periods belong mostly to that product. For problems specific to fillers that do not dissolve in the body, see our article “Complications of Permanent and Semi-Permanent Fillers”. These data are based on case reports; the true frequencies are not known with certainty.

Factors that increase the risk

  • Preparation of the product: not mixing the powdered product with enough fluid and for long enough, or using it too concentrated, has been associated with collection of the product and the risk of lumps.
  • Depth of placement: injecting the product too close to the surface increases the risk of lumps, especially in thin skin.
  • Too much product in one spot: injecting a large amount into a small area makes collection easier.
  • Area: constantly moving areas such as the lips and around the mouth, and areas with thin skin such as around the eyes, have been associated with more problems.
  • Areas that are risky for the blood vessels: areas such as the bridge of the nose, between the eyebrows, the forehead and the temples are considered riskier for vascular occlusion.
  • Personal characteristics: the immune response varies from person to person; in some people an inflammatory reaction can develop without a cause being found.

Most of these factors depend on the choices and technique of the physician performing the treatment. Your part is to describe all your illnesses, medicines and previous fillers and to follow the aftercare instructions. For general precautions, see our article “Reducing the Risk of Complications”.

Why do the lips and the area around the eyes need extra care?

Lips: in a long-term clinical review of 1,000 patients treated with calcium hydroxylapatite, almost all the lumps were reported to be in the lips. The systematic review of granulomas also names the area around the mouth as a high-risk area. A lump felt in the lip may also be mistaken for another condition during a dental examination; so tell your dentist too when and which product was used on your lips. For general problems with lip fillers, see our article “Lip Filler Complications”.

Eyelids and under the eyes: the skin in these areas is very thin; even a small collection of product can be felt and can become visible. In addition, the blood vessels around the eyes are connected to the vessels that supply the eye. Of the reported cases of vision loss after collagen-stimulating fillers, one developed after poly-L-lactic acid treatment around the eyes and nose, and one after treatment of the temple. For general information on fillers under the eyes, see our article “Under-Eye Filler Complications”.

Can collagen filler be dissolved? Why does hyaluronidase not work?

No, it cannot be dissolved with hyaluronidase. Hyaluronidase is an enzyme that breaks down only hyaluronic acid; poly-L-lactic acid, calcium hydroxylapatite and polycaprolactone have a different chemical structure. The FDA also states that fillers not made of hyaluronic acid can be difficult or even impossible to remove. These products are broken down by the body over time; however, this process can take months and years. How the enzyme works is explained in our article “Dissolving Filler (Hyaluronidase)”.

In some products, collagen-stimulating particles may be mixed with hyaluronic acid. In such a case, the enzyme may affect only the hyaluronic acid part; the particles remain in place. This is why it is important to know the exact contents of the product used on you.

The search for a substance that can dissolve calcium hydroxylapatite is ongoing. In a laboratory study using pig skin samples, a substance called sodium thiosulfate was shown to be able to dissolve this product; the author emphasised that larger studies in humans are needed. In humans there are only reports at the level of individual cases. The evidence is limited; today this substance should not be regarded as a 'dissolver' of proven effectiveness that takes the place of hyaluronidase.

Vascular occlusion: why is it especially important with collagen-stimulating fillers?

As with any filler, these products can accidentally be injected into a blood vessel. The FDA reports that this can lead to tissue death, vision problems, blindness and stroke. An international expert consensus on calcium hydroxylapatite also states that injection into a vessel can cause tissue loss, lasting scarring, vision problems and blindness, and that immediate intervention is needed in this situation.

In a review examining cases of vision loss related to collagen-stimulating fillers, at least 11 cases were found with calcium hydroxylapatite and 2 with poly-L-lactic acid; most of the calcium hydroxylapatite cases were associated with treatments of the bridge of the nose. Vision loss with polycaprolactone has not been published, but one case of a blocked facial blood vessel has been reported. These events are rare; even so, everyone who has filler in the face needs to know the warning signs.

With hyaluronic acid filler, the physician can try to dissolve the gel causing the blockage with the enzyme. With collagen-stimulating fillers there is no such dissolver; treatment relies on other methods aimed at supporting blood flow and protecting the tissue. This makes early recognition and seeking help without delay even more important. At the emergency department, be sure to say that the filler is not hyaluronic acid and give the name of the product.

Call 112 without waiting or go to the nearest emergency department

  • Blurred vision, loss of vision, double vision, a drooping eyelid or severe pain in the eye
  • Slurred speech, facial drooping, weakness or numbness in an arm or leg
  • Shortness of breath; rapidly increasing swelling of the lips, tongue or throat
  • Whitening, a purplish colour spreading like a net or severe, increasing pain in the treated area, if you cannot reach the physician who performed the treatment immediately

What can your physician do? Treatment options (general information)

Treatment is planned after an examination, according to the type of lump, the product, the area and how long the symptoms have lasted. The list below is for general information only; your physician decides which option is suitable for you.

  • Monitoring: most small non-inflammatory lumps that do not hurt and cannot be seen decrease over time; the physician will often first suggest waiting and monitoring.
  • Camouflage: one review states that visible non-inflammatory lumps can be concealed by applying hyaluronic acid filler around them. This does not remove the lump.
  • Injection of medicine into the area: for granulomas, medicines that suppress inflammation (such as corticosteroids), and sometimes medicines that slow cell growth, are used. In the systematic review, this was the most frequently used method. It can have side effects such as thinning of the skin; the amount and interval are entirely the physician’s decision.
  • If infection is suspected: medicine treatments chosen and monitored by the physician.
  • Surgical removal: may be considered for lumps that do not respond to other methods. The systematic review reports that granulomas often resolved with surgical removal; however, surgery also has its own risks, such as scarring.
  • Referral: if necessary, assessment together with specialists in dermatology, plastic surgery, ophthalmology or infectious diseases.

There are few strong studies comparing these treatments with one another; the recommendations are largely based on case series and expert opinion. Be cautious about approaches that promise fast and certain results.

What should you do if you notice a lump?

  1. If there are problems with vision or speech, loss of strength, shortness of breath or a sudden colour change in the area, call 112 without waiting.
  2. If there are no emergency signs, take a photo of the lump; note when you noticed it, its size and whether there is pain or redness.
  3. Contact the physician who performed the treatment; ask for, or take with you, the name of the product, the date of the treatment and the areas treated.
  4. Tell your physician about any recent infection, dental treatment or vaccination.
  5. If you cannot reach your physician or you do not feel reassured, you have the right to get an opinion from another physician. For the general steps, see our article “What Should You Do If a Complication Occurs after an Aesthetic Treatment?”.

What should you not do?

  • Do not try to break up a lump that appears weeks later by massaging it, squeezing it or piercing it with a needle.
  • Do not apply heat without consulting a physician.
  • Do not use antibiotics, cortisone medicines or creams on your own.
  • Do not have new filler in the same area somewhere else to hide the lump.
  • Do not use 'filler-dissolving' products sold online; they have no effect on these products anyway and carry additional risks.

This content is for information only; it does not replace an examination. The assessment and treatment that suit you can only be determined by a physician’s examination.

Questions to ask your physician

  1. Which product will be used on me; does it contain hyaluronic acid, and can you give me the product name and batch number in writing?
  2. What is the risk of lumps and vascular occlusion in this area?
  3. Is the lip or eye area a suitable area for this product?
  4. Which firm spots are normal in the first weeks, and when should I call you?
  5. If a lump appears months later, what course of action is taken?
  6. If vascular occlusion occurs, what is done, given that this product cannot be dissolved; do you have facilities for emergency intervention?
  7. If there is a problem outside working hours, how can I reach you?

Frequently asked questions

Is a lump after poly-L-lactic acid normal?

Small lumps in the first weeks that can be felt when touched, do not hurt and cannot be seen from the outside are the most widely known problem with this product, and most decrease over time. For lumps that become visible, grow, turn red or appear months later, contact the physician who performed the treatment. Do not try to break them up by massaging.

What are the side effects of 'collagen injections'?

Swelling, redness, tenderness and bruising are common in the first days. The most common problem specific to these products is lumps; inflammatory lumps (granulomas), infection and vascular occlusion are rare. Because vascular occlusion can lead to severe consequences such as vision loss and stroke, it is important to know the warning signs.

Can collagen filler be dissolved?

No. Hyaluronidase only dissolves hyaluronic acid; poly-L-lactic acid, calcium hydroxylapatite and polycaprolactone cannot be dissolved with this enzyme. The product is broken down in the body over time. Substances that may be able to dissolve calcium hydroxylapatite are being researched, but the evidence is limited.

Does firmness after calcium hydroxylapatite go away?

Most lumps reported with this product are not visible and pass on their own. Even so, firmness that grows, becomes visible or is painful needs an examination. Lumps have been reported more often in constantly moving areas such as the lips.

How long afterwards does a granuloma appear?

A granuloma mostly appears months, sometimes years later. In published cases, the time until the first symptom has been reported over a very wide range. So if you notice a new lump, tell your physician even if the filler was done years ago.

How is a granuloma treated?

Treatment is planned on the basis of the examination. The physician may consider monitoring, injecting a medicine that suppresses inflammation into the area, other medicines if necessary, or surgical removal. The treatments have not been well compared with one another and have their own side effects; do not use medicines on your own.

Can collagen-stimulating filler block a blood vessel?

Yes, although rarely, this has been reported; cases of vision loss are most often associated with areas such as the bridge of the nose and around the eyes. Because these products cannot be dissolved with an enzyme, seeking help early is even more important. If you have a vision problem, slurred speech or loss of strength, call 112 immediately.

Sources

  1. Dermal Fillers (Soft Tissue Fillers) — U.S. Food and Drug Administration (FDA)
  2. Understanding, avoiding, and treating potential adverse events following the use of injectable poly-L-lactic acid for facial and nonfacial volumization (Vleggaar D, Fitzgerald R, Lorenc ZP). J Drugs Dermatol 13(4 Suppl):s35–s39. PMID: 24719076 — Journal of Drugs in Dermatology, 2014
  3. Consensus Recommendations on the Diagnosis and Management of Noninflammatory and Inflammatory Nodules Secondary to Poly-L-Lactic Acid Injections (Rowland-Warmann MJ et al.). Aesthet Surg J, online ahead of print (sjag189). PMID: 42891685 — Aesthetic Surgery Journal, 2026
  4. Calcium hydroxylapatite: A review on safety and complications (Kadouch JA). J Cosmet Dermatol 16(2):152–161. PMID: 28247924 — Journal of Cosmetic Dermatology, 2017
  5. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation (Tzikas TL). Dermatol Surg 34 Suppl 1:S9–S15. PMID: 18547188 — Dermatologic Surgery, 2008
  6. Foreign Body Granulomas Reaction Related to Collagen Stimulatory Cosmetic Fillers: A Systematic Review (Wang H et al.). J Cosmet Dermatol 24(10):e70459. PMID: 41132036 — Journal of Cosmetic Dermatology, 2025
  7. Ultrasonographic Features of Polycaprolactone Granulomatous Reactions: Case Series and a Literature Review (Habibi S et al.). Aesthet Surg J Open Forum 8:ojag116. PMID: 42488346 — Aesthetic Surgery Journal Open Forum, 2026
  8. Visual Loss in Biostimulator Injectables: A Review of Incidence, Risk Factors, Etiology and Management Proposal (Young SM et al.). Aesthetic Plast Surg 50(5):1994–2005. PMID: 41263987 — Aesthetic Plastic Surgery, 2026
  9. Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus (van Loghem J et al.). J Cosmet Dermatol 19(11):2845–2858. PMID: 32185876 — Journal of Cosmetic Dermatology, 2020
  10. In Vitro Analysis of the Degradation of Calcium Hydroxylapatite Dermal Filler: A Proof-of-Concept Study (Robinson DM). Dermatol Surg 44 Suppl 1:S5–S9. PMID: 30358629 — Dermatologic Surgery, 2018
Share on WhatsApp

Related articles

This content is for information only and does not replace an examination or medical assessment. Ask your physician about your own situation.

This section contains no advertising, sponsored content or prices. Editorial Principles